PATENT CLAIM ANALYSIS

Application Number: 15919923
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "356000"]

Abstract:
Provided herein are pharmaceutical compositions that are useful for the treatment of hypertension comprising an angiotensin II receptor blocker, a diuretic, and a calcium channel blocker.

Claim (Index 27):
The pharmaceutical composition of  claim 26 , wherein the dose of the telmisartan is about 20 mg.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 90.0
- Lexical Diversity: 1.16
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15352425', '13766266', '14079464', '13799682', '13205545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7906744892796487
- 35 USC 102 Novelty (BERT): 0.5604409090575984
- Combined Prediction Score: 0.7676511312574437
- Mean Citation Score: 347.9151060000001
- Max Citation Score: 484.78262
- Similarity Product: 303.73677438503984

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test